Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: RG mentioning "public market listing"...

We are still in the same boat whether it's $20 or $25 million available for M/A. You can't use the stock, it's too cheap, you can't use any promise of money, too much uncertainity in future signings and the squelch of the settlement/NDA. Today, Mr. G sounds no different than Mr. T........... 

Goerner confirmed the companys commitment, and priority, to create increased shareholder value by expanding the business through strategic acquisitions in key technology segments.

Share
New Message
Please login to post a reply